Adefovir dipivoxil resistance patterns in patients with lamivudine-resistant chronic hepatitis B

Abstract

Although most patients showed virological breakthrough because of the well known rtA181V/T and rtN236T substitutions, more complex patterns were also found. ADV monotherapy, dose reduction and suboptimal virological response after 48 weeks of therapy were significantly associated with ADV resistance.